INTEST CORP
10-Q, 2000-05-12
INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS
Previous: GFSI HOLDINGS INC, 10-Q, 2000-05-12
Next: RSL COMMUNICATIONS LTD, 8-K, 2000-05-12






<PAGE>

                           UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                      WASHINGTON, D.C.  20549
                 ----------------------------------
                             FORM 10-Q

(Mark One)

[X]    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934

            For the quarterly period ended  March 31, 2000
                                           ------------------
                                 OR

[ ]    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934

            For the transition period from                 to
                                           ---------------    ---------------

                   Commission File Number 0-22529
                                          -------

                           inTEST Corporation
- -----------------------------------------------------------------------------
          (Exact Name of Registrant as Specified in its Charter)

            Delaware                                   22-2370659
- ---------------------------------           ---------------------------------
(State or other jurisdiction of            (I.R.S Employer Identification No.)
 incorporation or organization)

2 Pin Oak Lane, Cherry Hill, New Jersey                            08003
- ----------------------------------------                          --------
(Address of principal executive offices)                         (Zip Code)

Registrant's Telephone Number, Including Area Code:     (856) 424-6886
                                                       ------------------

Indicate by check X whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.

                          Yes   X     No
                              -----      -----

Number of shares of Common Stock, $.01 par value, outstanding as of March
31, 2000:

                                 8,582,827



<PAGE>

                         inTEST CORPORATION

                               INDEX


PART 1.  FINANCIAL INFORMATION
                                                                          Page
                                                                          ----
Item 1.  Financial Statements

         Consolidated Balance Sheets as of March 31, 2000 (unaudited)
         and December 31, 1999                                             1

         Consolidated Statements of Earnings (Loss) for the three
         months ended March 31, 2000 and 1999 (unaudited)                  2

         Consolidated Statements of Comprehensive Earnings (Loss)
         for the three months ended March 31, 2000 and 1999
         (unaudited)                                                       3

         Consolidated Statement of Stockholders' Equity for the three
         months ended March 31, 2000 (unaudited)                           4

         Consolidated Statements of Cash Flows for the three months
         ended March 31, 2000 and 1999 (unaudited)                         5

         Notes to Consolidated Financial Statements (unaudited)          6 -10

Item 2.  Management's Discussion and Analysis of Financial Condition
           and Results of Operations                                     11-16

Item 3.  Quantitative and Qualitative Disclosures About
           Market Risk                                                    17


PART II. OTHER INFORMATION

Item 1.  Legal Proceedings                                                18

Item 2.  Changes in Securities and Use of Proceeds                       19-20

Item 3.  Defaults Upon Senior Securities                                  20

Item 4.  Submission of Matters to a Vote of Securities Holders            21

Item 5.  Other Information                                                21

Item 6.  Exhibits and Reports on Form 8-K                                 21




<PAGE>

                   inTEST CORPORATION AND SUBSIDIARIES
                       CONSOLIDATED BALANCE SHEETS
                    (In thousands, except share data)

<TABLE>
<CAPTION>
                                                                March 31,    Dec. 31,
                                                                  2000         1999
                                                               ---------     --------
                                                              (Unaudited)    (Audited)
<S>                                                            <C>           <C>
ASSETS:
Current assets:
  Cash and cash equivalents                                     $ 8,682      $12,047
  Trade accounts and notes receivable, net of allowance for
    doubtful accounts of $238 and $239, respectively             13,819       10,020
  Inventories                                                     9,146        7,972
  Deferred tax asset                                              1,271        1,271
  Other current assets                                              652          898
                                                                -------      -------
     Total current assets                                        33,570       32,208
                                                                -------      -------
Machinery and equipment:
  Machinery and equipment                                         7,852        7,279
  Leasehold improvements                                          1,346        1,420
                                                                -------      -------
                                                                  9,198        8,699
  Less: accumulated depreciation                                 (6,257)      (6,002)
                                                                -------      -------
     Net machinery and equipment                                  2,941        2,697
                                                                -------      -------
Cash surrender value of life insurance                                -        1,067
Deferred tax asset                                                  350          350
Other assets                                                        394          288
Goodwill, net of accumulated amortization of $900
   and $780, respectively                                         6,286        6,405
                                                                -------      -------
     Total assets                                               $43,541      $43,015
                                                                =======      =======
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
  Notes payable to bank                                         $     -      $ 1,241
  Accounts payable                                                6,452        5,195
  Accrued expenses                                                2,706        3,011
  Current portion of long-term debt                                   -          123
  Domestic and foreign income taxes payable                       2,376        1,854
                                                                -------      -------
     Total current liabilities                                   11,534       11,424
                                                                -------      -------
Long-term debt, net of current portion                                -          133
                                                                -------      -------
     Total liabilities                                           11,534       11,557
                                                                -------      -------
Commitments

Stockholders' equity:
  Preferred stock, $0.01 par value; 5,000,000 shares authorized;
     no shares issued or outstanding                                  -            -
  Common stock, $0.01 par value; 20,000,000 shares authorized;
     8,582,827 and 8,630,980 shares issued, respectively             86           86
  Additional paid-in capital                                     21,681       21,872
  Retained earnings                                              13,555       13,077
  Accumulated other comprehensive earnings                            1           14
  Deferred compensation                                            (125)        (139)
  Note receivable from Equity Participation Plan                 (3,191)      (3,228)
  Treasury stock, at cost; 0 and 55,557 shares, respectively          -         (224)
                                                                -------      -------
     Total stockholders' equity                                  32,007       31,458
                                                                -------      -------
     Total liabilities and stockholders' equity                 $43,541      $43,015
                                                                =======      =======
</TABLE>
               See accompanying Notes to Consolidated Financial Statements.

                                       - 1 -


<PAGE>

                          inTEST CORPORATION AND SUBSIDIARIES
                          CONSOLIDATED STATEMENTS OF EARNINGS (LOSS)
                           (In thousands, except share data)
                                     (Unaudited)

<TABLE>
<CAPTION>

                                                             Three Months Ended
                                                                  March 31,
                                                             ------------------
                                                               2000       1999
                                                             -------    -------
<S>                                                          <C>        <C>
Net revenues                                                 $20,254    $ 8,223
Cost of revenues                                              10,279      4,471
                                                             -------    -------
      Gross margin                                             9,975      3,752
                                                             -------    -------
Operating expenses:
   Selling expense                                             2,318      1,538
   Engineering and product development expense                 1,450      1,067
   General and administrative expense                          1,473      1,087
   Merger-related costs                                        2,557          -
                                                             -------    -------
      Total operating expenses                                 7,798      3,692
                                                             -------    -------
Operating income                                               2,177         60
                                                             -------    -------
Other income (expense):
   Interest income                                               121         70
   Interest expense                                              (30)       (66)
   Other                                                           9          -
                                                             -------    -------
      Total other income                                         100          4
                                                             -------    -------
Earnings before income taxes                                   2,277         64

Income tax expense                                             1,799        125
                                                             -------    -------
      Net earnings (loss)                                    $   478    $   (61)
                                                             =======    =======

Net earnings (loss) per common share-basic                     $0.06     $(0.01)

Weighted average common shares
 outstanding-basic                                         8,137,167  8,061,730

Net earnings (loss) per common share-diluted                   $0.06     $(0.01)

Weighted average common shares and common
 share equivalents outstanding-diluted                     8,465,603  8,061,730

</TABLE>

          See accompanying Notes to Consolidated Financial Statements.


                                   - 2 -



<PAGE>

                    inTEST CORPORATION AND SUBSIDIARIES
             CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)
                     (In thousands, except share data)
                               (Unaudited)

<TABLE>
<CAPTION>

                                                      Three Months Ended
                                                            March 31,
                                                      ------------------
                                                        2000       1999
                                                      -------    -------

<S>                                                   <C>         <C>
Net earnings (loss)                                   $  478     $  (61)

Foreign currency translation adjustments                 (13)       (76)
                                                      ------     ------

Comprehensive earnings (loss)                         $  465     $ (137)
                                                      ======     ======

</TABLE>


        See accompanying Notes to Consolidated Financial Statements.


                                  - 3 -


<PAGE>

              inTEST CORPORATION AND SUBSIDIARIES
        CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
          FOR THE THREE MONTHS ENDED MARCH 31, 2000
             (In thousands, except share data)
         (Unaudited except Balance, December 31, 1999)

<TABLE>
<CAPTION>

                                                                  Accumulated
                                                                     Other
                               Common Stock  Additional          Comprehensive                   Equity                 Total
                            ----------------  Paid-In   Retained    Earnings      Deferred   Participation Treasury Stockholders'
                             Shares   Amount  Capital   Earnings   (Expense)    Compensation   Plan Note     Stock     Equity
                            --------- ------ ---------- -------- -------------- ------------ ------------- -------- ------------

<S>                         <C>        <C>     <C>       <C>          <C>         <C>           <C>         <C>        <C>

Balance, December 31, 1999  8,630,980  $ 86    $21,872   $13,077      $  14        $ (139)      $(3,228)    $(224)     $31,458

Net earnings                        -     -          -       478          -             -             -         -          478

Other comprehensive expense         -     -          -         -        (13)            -             -         -          (13)

Amortization of deferred
  compensation                      -     -          -         -          -            14             -         -           14

Principal payments by
  Equity Participation Plan         -     -          -         -          -             -            37         -           37

Stock options exercised         7,404     -         33         -          -             -             -         -           33

Retirement of treasury stock  (55,557)    -       (224)        -          -             -             -       224            -
                            ---------   ----    ------   -------      -----        ------       -------     -----      -------

Balance, March 31, 2000     8,582,827   $ 86    $21,681  $13,555      $   1        $ (125)      $(3,191)    $   -      $32,007
                            =========   ====    =======  =======      =====        ======       =======     =====      =======

</TABLE>

       See accompanying Notes to Consolidated Financial Statements.

                                 - 4 -


<PAGE>
                       inTEST CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                        (In thousands, except share data)
                                  (Unaudited)
<TABLE>
<CAPTION>
                                                               Three Months Ended
                                                                   March 31,
                                                               -----------------
                                                                 2000      1999
                                                               -------   -------
<S>                                                            <C>      <C>
CASH FLOWS FROM OPERATING ACTIVITIES
  Net earnings (loss)                                          $   478    $  (61)
  Adjustments to reconcile net earnings (loss) to net cash
   provided by (used in) operating activities:
    Depreciation                                                   287       213
    Amortization of goodwill                                       120       120
    Foreign exchange loss                                            7         9
    Allowance for doubtful accounts, net                            (1)       (3)
    Deferred compensation relating to stock options                 14        17
    Changes in assets and liabilities:
      Trade accounts and notes receivable                       (3,796)     (999)
      Inventories                                               (1,173)       11
      Proceeds from sale of demonstration equipment,
       net of gain                                                   7        28
      Refundable domestic and state income taxes                     -       975
      Other current assets                                         246       (22)
      Accounts payable                                           1,259       119
      Domestic and foreign income taxes payable                    530       323
      Accrued expenses                                            (298)       28
                                                               -------   -------
Net cash provided by (used in) operating activities             (2,320)      758
                                                               -------   -------
CASH FLOWS FROM INVESTING ACTIVITIES
  Purchase of machinery and equipment                             (551)      (99)
  Other long-term assets                                           958       (28)
                                                               -------   -------
Net cash provided by (used in) investing activities                407      (127)
                                                               -------   -------
CASH FLOWS FROM FINANCING ACTIVITIES
  Net repayments of revolving debt                              (1,241)     (392)
  Repayment of long-term debt                                     (256)      (37)
  Note receivable repayments from Equity Participation Plan         37        33
  Proceeds from stock options exercised                             33         -
                                                               -------   -------
Net cash used in financing activities                           (1,427)     (396)
                                                               -------   -------
Effects of exchange rates on cash                                  (25)      (52)
                                                               -------   -------
Net cash provided by (used in) all activities                   (3,365)      183
Cash and cash equivalents at beginning of period                12,047     8,637
                                                               -------   -------
Cash and cash equivalents at end of period                     $ 8,682   $ 8,820
                                                               =======   =======
</TABLE>

         See accompanying Notes to Consolidated Financial Statements.

                                    - 5 -


<PAGE>

                  inTEST CORPORATION AND SUBSIDIARIES
               NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
      (Information as of March 31, 2000 and for the three months ended
                  March 31, 2000 and 1999 is unaudited)
                 (In thousands, except for share data)

(1)  NATURE OF OPERATIONS

     inTEST Corporation (the "Company") is a leading independent designer,
     manufacturer and marketer of interface solutions and temperature
     management products that semiconductor manufacturers use in conjunction
     with automatic test equipment, or ATE, in the testing of integrated
     circuits, or ICs.  The Company's interface solutions products include
     manipulator, docking hardware, and tester interface products.

     The consolidated entity is comprised of inTEST Corporation (parent) and
     its eight 100% owned subsidiaries:  inTEST Limited (Thame, UK), inTEST
     Kabushiki Kaisha (Kichijoji, Japan), inTEST PTE, Limited (Singapore),
     inTEST Sunnyvale Corp. (Delaware), Temptronic Corporation (Delaware),
     inTEST Investments, Inc. (a Delaware holding company), inTEST IP Corp.
     (a Delaware holding company) and inTEST Licensing Corp. (a Delaware
     holding company).

     The Company manufactures its products in the U.S.,U.K. and Singapore
     (where the company commenced manufacturing during September 1999).
     Marketing and support activities are conducted worldwide from the
     Company's facilities in the U.S., U.K., Japan and Singapore.

     On March 9, 2000, the Company completed a merger with Temptronic
     Corporation ("Temptronic") whereby Temptronic was merged into a wholly-
     owned subsidiary of the Company.  The Company exchanged 2,046,793 shares
     of its common stock for all of the Temptronic common stock.  Each share
     of Temptronic common stock was exchanged for 0.925 shares of the
     Company's common stock.  In addition, outstanding Temptronic stock
     options were converted at the same exchange ratio into options to acquire
     175,686 shares of the Company's common stock. The merger was accounted
     for under the pooling-of-interests method of accounting and, accordingly,
     the accompanying consolidated financial statements have been
     retroactively restated to give effect to the merger.  Upon consummation
     of the merger, 55,557 shares of treasury stock held by Temptronic with a
     cost of $224 were retired.  Temptronic also has a 95% owned foreign
     subsidiary which is consolidated with Temptronic for reporting purposes.
     Minority interest in this foreign subsidiary is not material.

(2)  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     Basis of Presentation
     ---------------------

     The consolidated financial statements include the accounts of the
     Company and its wholly-owned subsidiaries.  All significant intercompany
     accounts and transactions have been eliminated upon consolidation.  The

                                 - 6 -


<PAGE>

                  inTEST CORPORATION AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                              (Unaudited)

(2)  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

     Basis of Presentation (Continued)
     ---------------------

     preparation of financial statements in conformity with generally
     accepted accounting principles requires management to make estimates and
     assumptions that affect the reported amounts of assets and liabilities
     and disclosure of contingent assets and liabilities at the date of the
     financial statements and the reported amounts of revenues and expenses
     during the reporting period.  Actual results could differ from those
     estimates.

     Interim Financial Reporting
     ---------------------------

     In the opinion of management, the accompanying unaudited consolidated
     financial statements include all adjustments (consisting only of
     normally recurring adjustments) necessary to present fairly the
     financial position, results of operations, and changes in cash flows
     for the interim periods presented.

     Certain footnote information has been condensed or omitted from these
     financial statements.  Therefore, these financial statements should be
     read in conjunction with the consolidated financial statements and
     accompanying footnotes included in the Company's Form 10-K for the year
     ended December 31, 1999.  Such financial statements and footnotes do not
     reflect the pooling of interests with Temptronic.

     Net Earnings Per Common Share
     -----------------------------

     Basic earnings per common share is computed by dividing net earnings
     (loss) by the weighted average number of common shares outstanding during
     each period.  Diluted earnings per common share is computed by dividing
     net earnings (loss) by the weighted average number of common shares and
     common share equivalents outstanding during each period.  Common share
     equivalents represent stock options using the treasury stock method.

     Weighted average common shares outstanding exclude unallocated shares of
     common stock held by the Company's Equity Participation Plan.

     New Accounting Pronouncements
     -----------------------------

     In June 1998, the Financial Accounting Standards Board issued SFAS
     No. 133, Accounting for Derivative Instruments and Hedging Activities,
     which establishes accounting and reporting standards for derivative

                                  - 7 -


<PAGE>

                  inTEST CORPORATION AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                              (Unaudited)


(2)  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

     New Accounting Pronouncements (Continued)
     -----------------------------

     instruments, including certain derivative instruments embedded in other
     contracts (collectively referred to as derivatives) and for hedging
     activities.  SFAS 133 is effective for all fiscal quarters of fiscal
     years beginning after June 15, 2000.  The Company plans to adopt this
     Statement in the first quarter of 2001, as required.  The adoption of
     this Statement is not expected to have a material effect on the results
     of operations, financial condition or long-term liquidity of the Company.


(3)  SEGMENT INFORMATION

     The various products the Company designs, manufactures and markets, which
     include manipulator, docking hardware, tester interface and
     temperature management products, are considered by management to be a
     single product segment.  Included in this segment are products the
     Company designs and markets that are manufactured by third parties, which
     include high performance test sockets and interface boards.  The Company
     operates its business worldwide and divides the world into three
     geographic segments:  North America, Asia-Pacific and Europe.  The North
     America segment includes the Company's manufacturing, design and service
     facilities in New Jersey, California and Massachusetts; the Asia-Pacific
     segment includes the Company's manufacturing, design and service
     facilities in Singapore and the Company's design and service facilities
     in Japan; and the Europe segment includes the Company's manufacturing,
     design and service facility in the U.K.  Each segment sells Company
     designed and manufactured products, while products produced by third
     party manufacturers are primarily distributed by the Company's Asia-
     Pacific segment.  All three segments sell to semiconductor manufacturers
     and automatic test equipment manufacturers.  The North America segment
     sells through Company account managers, independent sales representatives
     and distributors; the Asia-Pacific segment sells through Company account
     managers and independent sales representatives; and the Europe segment
     sells through Company account managers and distributors.

     Intercompany pricing between segments is either a multiple of cost for
     component parts used in manufacturing or a percentage discount from list
     price for finished goods sold to non-manufacturing segments.


                                  - 8 -



<PAGE>

                  inTEST CORPORATION AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                              (Unaudited)

(3)  SEGMENT INFORMATION (Continued)

<TABLE>
<CAPTION>
                                                       Three Months Ended
                                                            March 31,
                                                       ------------------
                                                         2000      1999
                                                       -------    -------
     <S>                                               <C>        <C>
     Net revenues from unaffiliated customers:
       North America                                   $16,148    $6,854
       Asia-Pacific                                      2,100       958
       Europe                                            2,006       411
                                                       -------    ------
                                                       $20,254    $8,223
                                                       =======    ======
     Affiliate sales or transfers from:
       North America                                   $   879    $  417
       Asia-Pacific                                         10         -
       Europe                                              125        92
                                                       -------    ------
                                                       $ 1,014    $  509
                                                       =======    ======
     Operating income (loss):
       North America                                   $   672    $   25
       Asia-Pacific                                        461        77
       Europe                                            1,044       (42)
                                                       -------    ------
                                                       $ 2,177    $   60
                                                       =======    ======
     Earnings (loss) before income taxes:
       North America                                   $   750    $   18
       Asia-Pacific                                        486        85
       Europe                                            1,041       (39)
                                                       -------    ------
                                                       $ 2,277    $   64
                                                       =======    ======
     Net earnings (loss):
       North America                                   $  (614)   $  (49)
       Asia-Pacific                                        308         8
       Europe                                              784       (20)
                                                       -------    ------
                                                       $   478    $  (61)
                                                       =======    ======
</TABLE>

      The $2.6 million of merger-related costs were incurred by the North
      America segment.


                                         -9-


<PAGE>

                  inTEST CORPORATION AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                              (Unaudited)




(4)  LEGAL PROCEEDINGS

     As previously reported, on April 16, 1999, the Company and its
     subsidiary, inTEST IP Corp.(which holds title to all our intellectual
     property) filed suit against a competitor for infringement of a United
     States patent held by the Company (the "815 Patent").  The invention
     disclosed and claimed in the 815 Patent is directed to a system for
     positioning and docking a test head to a device handler and is used in
     the testing of integrated circuits.  The Company sells docking hardware
     products covered by the 815 Patent worldwide.

     As alleged in the complaint, the competitor began manufacturing, offering
     to sell, and selling products as early as 1991 that, without license,
     infringed upon the claims of the 815 Patent.  The complaint asked the
     court to enjoin the competitor from further acts of infringement and
     award the Company damages, including lost profits, from the infringing
     product sales.

     On March 31, 2000, the Company entered into a settlement agreement with
     the competitor under which it agreed to dismiss the suit.  The
     settlement agreement provides, among other things, that the competitor
     acknowledged the validity of the 815 Patent with regard to its existing
     docking hardware products, agreed to pay the Company $300,000 over two
     years, became a licensee under the 815 Patent and agreed to pay royalties
     to the Company for future sales of its current design of docking hardware
     products.

     All legal fees incurred in connection with this matter have been expensed
     and the amounts to be received for settlement of the suit will be offset
     against these previously incurred expenses.



                                   - 10 -


<PAGE>

                   inTEST CORPORATION AND SUBSIDIARIES

Item 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
          RESULTS OF OPERATIONS.


Overview
- --------

     We are a leading independent designer, manufacturer and marketer of
interface solutions and temperature management products that semiconductor
manufacturers use in conjunction with automatic test equipment, or ATE, in the
testing of integrated circuits, or ICs.  Our interface solutions products
include manipulator, docking hardware and tester interface products.  Our high
performance products are designed to enable semiconductor manufacturers to
improve the efficiency of their IC test processes and, consequently, their
profitability.  We supply our products worldwide to major semiconductor
manufacturers directly and through leading ATE manufacturers.

     Our revenues depend substantially upon the demand for ATE by
semiconductor manufacturers and, therefore, fluctuate generally in response to
the cyclicality in the semiconductor manufacturing industry.  During the past
several years, the demand for ATE by the semiconductor industry has exhibited
a high degree of cyclicality.  Our first quarter results reflect the
continuation of a period of growth in the semiconductor industry which has
been evidenced by our sequential quarterly growth in net revenues which grew
from $8.2 million for the quarter ended March 31, 1999 to a record $20.3
million for the quarter ended March 31, 2000.  Orders for our products
("bookings") were a record $21.8 million for the quarter ended March 31,
2000 compared with $12.0 million for the quarter ended March 31, 1999.  As a
result of our increased bookings, our backlog increased from $8.1 million at
March 31, 1999 to $17.6 million at March 31, 2000.  We believe that the
increases in our net revenues, bookings, and backlog reflect the increased
demand for ATE by semiconductor manufacturers.  Although we calculate bookings
and backlog on the basis of firm orders, we cannot give any assurance that
customers will purchase the equipment subject to such orders.  As a result,
our bookings for any period and backlog at any particular date do not
necessarily serve as an indicator of actual sales for any succeeding period.


Significant Events
- ------------------

     On March 9, 2000, we acquired Temptronic Corporation.  The acquisition
was in the form of a merger of Temptronic into a subsidiary of ours, and was
accounted for as a pooling of interests.  The following discussion describes
our results of operations and financial condition on a pooled basis.

                                  - 11 -



<PAGE>

             inTEST CORPORATION AND SUBSIDIARIES

Item 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
          RESULTS OF OPERATIONS (Continued)

Results of Operations
- ---------------------

Three Months Ended March 31, 2000 Compared to Three Months Ended March 31,
1999:

     Net Revenues.  Net revenues were a record $20.3 million for the quarter
ended March 31, 2000 compared to $8.2 million for the same period in 1999, an
increase of $12.0 million or 146%.  We believe that the significant increase
in net revenues over the comparable prior period is principally the result of
continued growth in the demand for ATE in 2000 compared to 1999.

     Gross Margin.  Gross margin increased to 49% for the quarter ended
March 31, 2000 from 46% for the comparable period in 1999.  The improvement in
gross margin primarily resulted from the absorption of fixed manufacturing
costs over significantly higher net revenue levels in 2000 compared to 1999.
Also contributing to the improvement in gross margin were production
methodology improvements implemented in 1999 by Temptronic, which were offset,
in part, by increases in fixed manufacturing costs resulting from
manufacturing capacity increases during 1999.

     Selling Expense.  Selling expense was $2.3 million for the quarter ended
March 31, 2000 compared to $1.5 million for the same period in 1999, an
increase of $780,000 or 51%.  We attribute the increase primarily to increased
commission expense resulting from the higher sales levels in 2000, as well as
higher levels of warranty costs, travel expenditures, freight expense and
increases in salary expense resulting from new sales and marketing staff hired
in 1999.

     Engineering and Product Development Expense.  Engineering and product
development expense was $1.5 million for the quarter ended March 31, 2000
compared to $1.1 million for the same period in 1999, an increase of $383,000
or 36%.  We attribute the increase primarily to the salary expense of
additional engineering and technical staff, as well as increased expenditures
for product development materials and travel expenses associated with new
product development.

     General and Administrative Expense.  General and administrative expense
was $1.5 million for the quarter ended March 31, 2000 compared to $1.1 million
for the same period in 1999, an increase of $386,000 or 36%.  We attribute the
increase primarily to higher administrative salary expense resulting from
staffing additions and salary increases for existing staff, as well as
incentive compensation increases for existing staff, increases in investor
relations expense and professional fees, partially offset by $200,000 received
during the quarter from the settlement of patent infringement litigation.

                                    - 12 -


<PAGE>

                   inTEST CORPORATION AND SUBSIDIARIES

Item 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
          RESULTS OF OPERATIONS (Continued)


      Merger-related Costs.  Merger-related costs resulting from the Company's
merger with Temptronic Corporation were $2.6 million, which consisted of fees
paid to investment bankers, professional fees, printing, escrow and other
miscellaneous costs.  We do not expect to record any further costs related to
the merger in future periods.


     Income Tax Expense.  Income tax expense increased to $1.8 million for the
quarter ended March 31, 2000 from $125,000 for the comparable period in
1999, an increase of $1.7 million.  Our effective tax rate for the first
quarter of 2000 was 79% due to the recognition of $2.3 million of non-tax
deductible merger-related costs.  In addition, we recognized a $237,000
taxable gain on the liquidation of life insurance policies held on certain
former Temptronic officers and directors.  The effective tax rate for the
first quarter of 1999 was 195% because no current tax benefit was recorded for
Temptronic's operating loss during the quarter.


Liquidity and Capital Resources
- -------------------------------

     Net cash used in operations for the three months ended March 31,
2000 was $2.3 million.  Accounts receivable increased $3.8 million from
December 31, 1999 to March 31, 2000 due to the increase in sales activity
during the first quarter of 2000.  Inventories increased $1.2 million, also as
a result of the increased sales activity as we made purchases for future
product shipments.  Other current assets decreased $246,000, primarily as a
result of the expensing of previously capitalized merger-related costs.
Accounts payable increased $1.3 million due to the higher production levels
during the first quarter of 2000.  Accrued expenses decreased $298,000 as a
result of the payment of previously accrued expenses including sales
commissions, salaries, incentive compensation and professional fees.  The
decline in accrued expenses was offset, in part, by an accrual for merger-
related costs to be paid in future periods.  Domestic and foreign income taxes
payable increased $530,000 as a result of the accrual of income taxes on the
earnings for the first quarter of 2000.

     Purchases of machinery and equipment were $551,000 for the quarter ended
March 31, 2000, which consisted primarily of improvements to the Company's
facilities in the United States.  During the quarter, we spent approximately
$205,000 on furnishings, $162,000 on equipment and $19,000 on leasehold
improvements at our new facility for our inTEST Sunnyvale operation, which
relocated during the quarter.  We estimate that we will spend an additional
$350,000 on leasehold improvements to complete this facility in the next

                                  - 13 -


<PAGE>

                   inTEST CORPORATION AND SUBSIDIARIES

Item 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
          RESULTS OF OPERATIONS (Continued)

quarter.  Our lease on this facility entitles us to a reimbursement of
approximately $250,000 of the amount we spend on leasehold improvements and we
expect to receive this reimbursement during the third quarter of 2000.  We
spent approximately $115,000 on manufacturing and computer equipment at
various other domestic operations during the quarter.  We plan to relocate our
headquarters and primary manufacturing facility during the third quarter of
2000 and we estimate the total cost of leasehold improvements and other costs
associated with the move will be approximately $800,000.

     Other long-term assets decreased $958,000 primarily as a result of the
liquidation of life insurance policies held on certain former Temptronic
officers and directors.

     Net cash used in financing activities for the quarter ended March 31,
2000 was $1.4 million.  During the quarter we repaid approximately $1.2
million under revolving lines of credit as well as $247,000 of long-term debt
acquired as a result of the merger with Temptronic.

     We believe that our existing cash balances and lines of credit plus the
anticipated net cash provided from operations will be sufficient to satisfy
our cash requirements for the foreseeable future.  However, future
acquisitions may require additional equity or debt financing to meet working
capital requirements or capital expenditure needs.  We do not anticipate
paying dividends in the foreseeable future.

International Operations
- ------------------------

     Net revenues generated by our foreign subsidiaries were 20% and 17% of
consolidated net revenues for the quarters ended March 31, 2000 and 1999,
respectively.  We anticipate that net revenues generated by our foreign
subsidiaries will continue to account for a significant portion of
consolidated net revenues in the foreseeable future.  The net revenues
generated by our foreign subsidiaries will continue to be subject to certain
risks, including political and economic instability of foreign countries, the
imposition of financial and operational controls or regulatory restrictions by
foreign governments, the need to comply with a variety of U. S. and foreign
export and import laws, trade restrictions, changes in tariffs and taxes,
longer payment cycles, fluctuations in foreign currency exchange rates, and
the greater difficulty of administering business abroad.  We cannot predict
whether quotas, duties, taxes or other charges or restrictions will be
implemented by the United States or any other country upon the importation or
exportation of our products in the future.  Any of these factors or the
adoption of restrictive policies could have a material adverse effect on our
business, financial condition or results of operations.

                                   - 14 -


<PAGE>

                   inTEST CORPORATION AND SUBSIDIARIES

Item 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
          RESULTS OF OPERATIONS (Continued)

International Operations (Continued)
- ------------------------

     Net revenues denominated in foreign currencies were 15% and 11% of
consolidated revenues for the quarters ended March 31, 2000 and 1999,
respectively.  Although we seek to operate our business such that a
significant portion of our product costs are denominated in the same currency
that the associated sales are made in, we may be adversely affected in the
future due to our exposure to foreign operations.  Moreover, net revenues
denominated in currencies other than U.S. dollars expose us to currency
fluctuations, which can adversely affect results of operations.

     The portion of our consolidated net revenues that were derived from sales
to the Asia-Pacific region were 10% and 12% for the quarters ended March 31,
2000 and 1999, respectively.  Countries in the Asia-Pacific region, including
Japan, have experienced economic instability resulting in weaknesses in their
currency, banking and equity markets.   Although the past economic instability
in the Asia-Pacific region has not materially adversely affected our order
backlog, balance sheet, or results of operations to date, continued economic
instability could have a material adverse effect on demand for our products
and our consolidated results of operations.

Cautionary Statement Regarding Forward-Looking Statements
- ---------------------------------------------------------

     This Report contains statements of a forward-looking nature relating to
future events, such as statements regarding the anticipated market for our
products throughout the balance of 2000; costs related to our merger with
Temptronic Corporation; additional expenditures for leasehold improvements for
our new Sunnyvale facility; expenditures for leasehold improvements and moving
costs for our new headquarters and primary manufacturing facility; anticipated
reimbursement on certain expenditures for leasehold improvements; anticipated
net revenues generated by foreign operations; sufficiency of cash balances,
lines of credit and net cash from operations; and use of forward exchange rate
contracts.  Forward-looking statements typically can be identified by the use
of terminology such as "believes," expects," "may," "will," "should" or
"anticipates" or the negative thereof or other variations thereon or
comparable terminology, or by discussions of strategy that involve risks and
uncertainties.  Investors and prospective investors are cautioned that such
statements are only projections and that actual events or results may differ
materially from those expressed in any such forward-looking statements.  In
addition to the factors described in this Report, our actual consolidated
quarterly or annual operating results have been affected in the past, or could
be affected in the future, by additional factors, including, without
limitation: changes in business conditions and the economy, generally; our
ability to obtain patent protection, and enforce our patent rights, for
existing and developing proprietary technologies; our ability to integrate
successfully businesses, technologies or products which we may acquire; the
effect of the loss of, or reduction in orders from, a major customer;


                                   - 15 -


<PAGE>

                   inTEST CORPORATION AND SUBSIDIARIES

Item 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
          RESULTS OF OPERATIONS (Continued)

Cautionary Statement Regarding Forward-Looking Statements (Continued)
- ---------------------------------------------------------

cancellation, or delays in shipment of, orders in our backlog; competition
from other manufacturers of docking hardware, test head manipulators, tester
interfaces and related ATE interface products and temperature management
products; cost overruns relating to leasehold improvements  for our new
Sunnyvale facility; cost overruns relating to leasehold improvements and
moving costs for our new headquarters and primary manufacturing facility;
unanticipated exchange rate fluctuations; delays in reimbursement payment for
leasehold improvements; and capital requirements relating to future
acquisitions.

                                 - 16 -


<PAGE>

                    inTEST CORPORATION AND SUBSIDIARIES

Item 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


      We are exposed to currency exchange rate risk in the normal course of
our business, primarily in our Japanese operations.  Our exposure results from
the fact that the sales of our Japanese subsidiary are in Japanese yen and
inventory purchases are in U.S. dollars.  We will have a similar exposure in
our Singapore operations as our manufacturing operations, which commenced in
September 1999, expand, because our sales will be in U.S. dollars but our
manufacturing costs will be primarily in Singapore dollars.  We employ risk
management strategies, including the use of forward exchange rate contracts,
to manage our exposure to exchange rate risks involving the yen, and may, in
the future, use forward exchange rate contracts to manage our exposure to
exchange rate risks involving the Singapore dollar.

      Our objective in managing currency exchange risk is to minimize the
impact of significant currency exchange rate fluctuations.  We use forward
exchange rate contracts to establish a fixed conversion rate between the
Japanese yen and the U.S. dollar so that the level of our gross margin from
sales in Japan is not negatively affected by significant movements in the
Japanese yen to U.S. dollar exchange rate.  We purchase forward exchange rate
contracts on a monthly basis in the amounts management deems appropriate in
light of the amount of the U.S. dollar denominated obligations of our Japanese
subsidiary that are due within the month.  We do not purchase forward
contracts with settlement dates beyond 30 days.  As of March 31, 2000, there
were no forward exchange rate contracts outstanding.

      It is our policy to enter into forward exchange rate contracts only to
the extent necessary to achieve the desired objectives of management in
limiting our exposure to significant fluctuations in currency exchange rates.
We do not expect that the results of our operations or our liquidity will be
materially affected by these risk management activities.  We do not hedge all
of our currency exchange rate risk exposures in a manner that would completely
eliminate the impact of changes in currency exchange rates on our net
earnings.


                                 - 17 -


<PAGE>


                              inTEST CORPORATION


PART II.  OTHER INFORMATION


Item 1.  Legal Proceedings


     As previously reported, on April 16, 1999, we and our subsidiary, inTEST
     IP Corp.(which holds title to all our intellectual property) filed suit
     against a competitor for infringement of a United States patent held by
     us (the "815 Patent").  The invention disclosed and claimed in the 815
     Patent is directed to a system for positioning and docking a test head to
     a device handler and is used in the testing of integrated circuits.  We
     sell docking hardware products covered by the 815 Patent worldwide.

     As alleged in the complaint, the competitor began manufacturing, offering
     to sell, and selling products as early as 1991 that, without license,
     infringed upon the claims of the 815 Patent.  The complaint asked the
     court to enjoin the competitor from further acts of infringement and
     award us damages, including lost profits, from the infringing product
     sales.

     On March 31, 2000, we entered into a settlement agreement with the
     competitor under which we agreed to dismiss the suit.  The settlement
     agreement provides, among other things, that the competitor acknowledged
     the validity of the 815 Patent with regard to its existing docking
     hardware products, agreed to pay us $300,000 over two years, became a
     licensee under the 815 Patent and agreed to pay royalties to us for
     future sales of its current design of docking hardware products.

     All legal fees incurred in connection with this matter have been expensed
     and the amounts to be received for settlement of the suit will be offset
     against these previously incurred expenses.




                                    - 18 -


<PAGE>

                             inTEST CORPORATION

PART II.  OTHER INFORMATION (Continued)

Item 2.   Changes in Securities and Use of Proceeds

          On June 17, 1997, the Company's Registration Statement on
          Form S-1 covering the Offering of 2,275,000 shares of the
          Company's Common Stock, Commission file number 333-26457,
          was declared effective.  The Offering commenced on
          June 20, 1997, managed by Janney Montgomery Scott, Inc.
          and Needham & Company, Inc. as representatives of the
          several underwriters named in the Registration Statement
          (the "Underwriters").

          Of the 2,275,000 shares sold pursuant to the Offering,
          1,820,000 shares were sold by the Company and 455,000 were sold
          by certain selling stockholders (the "Selling Stockholders").
          In addition, the Underwriters exercised an over-allotment option
          to purchase an additional 341,250 shares of the Company's Common
          Stock from the Selling Stockholders.  The total price to the
          public for the shares offered and sold by the Company and the
          Selling Stockholders was $13,650,000 and $5,971,875,
          respectively.

          The amount of expenses incurred for the Company's account in
          connection with the Offering were as follows:

          <TABLE>

          <S>                                               <C>
          Underwriting discounts and commissions:            $1,023,750
          Finders' fees:                                           None
          Expenses paid to or for the Underwriters:              16,650
          Other expenses:                                       954,758
                                                             ----------
          Total expenses:                                    $1,995,158
                                                             ==========
          </TABLE>

          All of the foregoing expenses were direct or indirect payments
          to persons other than (i) directors, officers or their
          associates; (ii) persons owning ten percent (10%) or more of the
          Company's Common Stock; or (iii) affiliates of the Company.

          The net proceeds of the Offering to the Company (after deducting
          the foregoing expenses) was $11,654,842.  From the effective
          date of the Registration Statement, the net proceeds have been
          used for the following purposes:

                                    - 19 -


<PAGE>

                            inTEST CORPORATION


PART II.  OTHER INFORMATION (Continued)


Item 2.   Changes in Securities and Use of Proceeds (Continued)

          <TABLE>

          <S>                                                <C>
          Construction of plant, building and facilities     $         -
          Purchase and installation of machinery
            and equipment                                      2,171,538
          Purchase of real estate                                      -
          Acquisition of other businesses (including
            transaction costs)                                 6,565,349
          Repayment of indebtedness                            1,717,465
          Working capital                                        599,725
          Temporary investments, including cash &
            cash equivalents                                           -
          Other purposes (for which at least $100,000
            has been used), including:
               Payment of final S corporation distribution       600,765
                                                             -----------
                                                             $11,654,842
                                                             ===========

          </TABLE>


          In connection with the termination of the Company's status as
          an S corporation, the Company used $600,765 of the net proceeds
          to pay a portion of the $4.3 million final distribution of
          previously taxed but undistributed earnings of the Company.

          All of the foregoing payments with the exception of the final S
          corporation distribution were direct or indirect payments to
          persons other than (i) directors, officers or their associates;
          (ii) persons owning ten percent (10%) or more of the Company's
          Common Stock; or (iii) affiliates of the Company.


Item 3.   Defaults Upon Senior Securities

          None





                                   - 20 -


<PAGE>

                            inTEST CORPORATION

PART II.  OTHER INFORMATION (Continued)

Item 4.   Submission of Matters to a Vote of Securities Holders

          During the first quarter of 2000, a Special Meeting of Shareholders
          was held on March 9, 2000 for the purpose of considering and voting
          upon the proposal to approve the merger agreement among inTEST,
          Temptronic Corporation and one of our wholly-owned subsidiaries.

          The number of votes cast for or against as well as the number of
          abstentions and broker non-votes for the above proposal were as
          follows:

         <TABLE>
         <CAPTION>
            For              Against        Abstentions     Broker Non-Votes
         ---------           -------        -----------     ----------------
         <C>                  <C>              <C>                <C>
         5,445,958             1,500            350                0

         </TABLE>

Item 5.   Other Information

          None

Item 6.   Exhibits and Reports on Form 8-K

          (a) Exhibits:

              3.1   Articles of Incorporation: Previously filed by the
                    Company as an Exhibit to the Company's Registration
                    Statement on Form S-1, File No. 333-26457, and
                    Incorporated herein by reference.

              3.2   By-Laws: Previously filed by the Company as an Exhibit
                    to the Company's Registration Statement on Form S-1,
                    File No. 333-26457, and incorporated herein by
                    reference.

              27    Financial Data Schedule

          (b) Reports on Form 8-K

              1)  8-K dated March 9, 2000 providing information responsive
                  to the requirements of Item 2 and 7 of that form.

                                    - 21-


<PAGE>

                            Signatures





Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.




                                       inTEST Corporation



Date:   May 12, 2000                   /s/ Robert E. Matthiessen
       ------------------              -------------------------------------
                                       Robert E. Matthiessen
                                       President and Chief Executive Officer



Date:   May 12, 2000                   /s/ Hugh T. Regan, Jr.
       ------------------              -------------------------------------
                                       Hugh T. Regan, Jr.
                                       Treasurer and Chief Financial Officer




<PAGE>
                             Index to Exhibits


Item 6.   Exhibits and Reports on Form 8-K

          3.1   Articles of Incorporation: Previously filed by the
                Company as an Exhibit to the Company's Registration
                Statement on Form S-1, File No. 333-26457, and
                Incorporated herein by reference.

          3.2   By-Laws: Previously filed by the Company as an Exhibit
                to the Company's Registration Statement on Form S-1,
                File No. 333-26457, and incorporated herein by
                reference.

          27    Financial Data Schedule


<TABLE> <S> <C>

<ARTICLE>           5
<CIK>               0001036262
<NAME>              INTEST CORPORATION
<MULTIPLIER>        1,000



<S>                         <C>
<PERIOD-TYPE>               3-MOS
<FISCAL-YEAR-END>                    DEC-31-2000
<PERIOD-START>                       JAN-01-2000
<PERIOD-END>                         MAR-31-2000
<CASH>                                     8,682
<SECURITIES>                                   0
<RECEIVABLES>                             13,819
<ALLOWANCES>                                 238
<INVENTORY>                                9,146
<CURRENT-ASSETS>                          33,570
<PP&E>                                     9,198
<DEPRECIATION>                             6,257
<TOTAL-ASSETS>                            43,541
<CURRENT-LIABILITIES>                     11,534
<BONDS>                                        0
                          0
                                    0
<COMMON>                                      86
<OTHER-SE>                                31,921
<TOTAL-LIABILITY-AND-EQUITY>              43,541
<SALES>                                   20,254
<TOTAL-REVENUES>                          20,254
<CGS>                                     10,279
<TOTAL-COSTS>                              7,798
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                            30
<INCOME-PRETAX>                            2,277
<INCOME-TAX>                               1,799
<INCOME-CONTINUING>                          478
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                 478
<EPS-BASIC>                                .06
<EPS-DILUTED>                                .06



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission